Solicitation
Post-Market Bioequivalence of Generic Drug Products
Amendment75F40123R00023
Food and Drug Administration, FDA Center for Drug Evaluation and Research. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Response deadline
February 29, 2024 at 10:00 AM EST
Closed 931 days ago. Posted February 21, 2024, first published February 9, 2024. Scheduled to archive March 15, 2024.
Description
As published on SAM.gov.
This posting serves as an amendment to Solicitation 75F40124R00023. Q&A were revised, see attached. Proposals are due 10EST 02/29/2024
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- Telisha WIlsontelisha.wilson@fda.hhs.gov